BARD1 silencing also downregulated the level of total AKT and phospho-AKT as well as its downstream effectors, such as total mTOR, phospho-mTOR, and MMP9, suggesting that HCC tumor survival is mediated through BARD1 activation of the AKT pathway and is independent of p53. The gene discussed is MTOR; the disease is neoplasm.